Parmetol K 50
61840-43-5
|
Parmetol A 23
61840-41-3
|
kingianoside K
1241947-65-8
|
Benzo[k]fluoranthene-d12
93952-01-3
|
luperoside K
124792-11-6
|
Cathepsin K inhibitor 3
1694638-70-4
|
neuromedin K, cyclic Cys(2,5)-
104953-10-8
|
K252C
85753-43-1
|
Neuropeptide K (human, porcine, rat) trifluoroacetate salt
96827-05-3
|
2,2-dimethyl-N-[4-({[(pyridin-3-yl)methyl]carbamoyl}methyl)-1,3-thiazol-2-yl]propanamide
921844-28-2
|
N-(4-(2-oxo-2-((4-phenoxyphenyl)amino)ethyl)thiazol-2-yl)pivalamide
921776-34-3
|
N-(4-{[(2,4-dimethoxyphenyl)carbamoyl]methyl}-1,3-thiazol-2-yl)-2,2-dimethylpropanamide
921547-05-9
|
N-(4-(2-((3-chlorophenyl)amino)-2-oxoethyl)thiazol-2-yl)pivalamide
69439-14-1
|
N-(4-{[(3-fluorophenyl)carbamoyl]methyl}-1,3-thiazol-2-yl)-2,2-dimethylpropanamide
921546-56-7
|
N-(4-{[(2-methoxyphenyl)carbamoyl]methyl}-1,3-thiazol-2-yl)-2,2-dimethylpropanamide
921776-22-9
|
N-(4-(2-(benzo[d]thiazol-2-ylamino)-2-oxoethyl)thiazol-2-yl)pivalamide
921547-33-3
|
5-(2-Bromophenyl)nicotinic acid
887973-35-5
|
2-[(3-hexyl-4,8-dimethyl-2-oxo-2H-chromen-7-yl)oxy]acetamide
438030-44-5
|
5-(Benzo[D][1,3]dioxol-5-YL)nicotinaldehyde
887973-93-5
|
